Zhao H - Search Results

1

18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.

Xie P, Li M, Zhao H, Sun X, Fu Z, Yu J. Xie P, et al. Among authors: zhao h. J Cancer Res Clin Oncol. 2011 Jul;137(7):1085-93. doi: 10.1007/s00432-010-0972-y. Epub 2011 Jan 13. J Cancer Res Clin Oncol. 2011. PMID: 21229262

2

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.

Xie P, Yue JB, Zhao HX, Sun XD, Kong L, Fu Z, Yu JM. Xie P, et al. J Cancer Res Clin Oncol. 2010 Jun;136(6):883-9. doi: 10.1007/s00432-009-0729-7. Epub 2009 Nov 20. J Cancer Res Clin Oncol. 2010. PMID: 19936788

3

[From the local tumor recurrence status to discuss the target delineation in radiotherapy for non-small cell lung cancer].

Sun XD, Yue JB, Zhao HX. Sun XD, et al. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):454-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950558 Chinese. No abstract available.

4

A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.

Zhao H, Zhu W, Xie P, Li H, Zhang X, Sun X, Yu J, Xing L. Zhao H, et al. Radiother Oncol. 2014 Jan;110(1):132-6. doi: 10.1016/j.radonc.2013.10.014. Epub 2014 Jan 17. Radiother Oncol. 2014. PMID: 24444526 Clinical Trial.

5

A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer.

Zhao H, Xie P, Li X, Zhu W, Sun X, Sun X, Chen X, Xing L, Yu J. Zhao H, et al. Radiother Oncol. 2015 Mar;114(3):351-6. doi: 10.1016/j.radonc.2015.02.014. Epub 2015 Mar 10. Radiother Oncol. 2015. PMID: 25769379 Clinical Trial.

6

Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.

Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, Li X, Meng X, Kong L, Xing L, Yu J. Zhao H, et al. Among authors: zhao x. Br J Radiol. 2016;89(1058):20150665. doi: 10.1259/bjr.20150665. Epub 2015 Nov 26. Br J Radiol. 2016. PMID: 26607642 Free PMC article. Clinical Trial.

7

MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF.

Meng X, Li H, Kong L, Zhao X, Huang Z, Zhao H, Zhu W, Li X, Yu J, Xing L. Meng X, et al. Among authors: zhao x, zhao h. J Magn Reson Imaging. 2016 Sep;44(3):594-600. doi: 10.1002/jmri.25195. Epub 2016 Feb 26. J Magn Reson Imaging. 2016. PMID: 26919464

8

Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.

Zhu W, Jia L, Chen G, Zhao H, Sun X, Meng X, Zhao X, Xing L, Yu J, Zheng M. Zhu W, et al. Among authors: zhao h, zhao x. Oncotarget. 2016 Jul 26;7(30):48607-48613. doi: 10.18632/oncotarget.9495. Oncotarget. 2016. PMID: 27224910 Free PMC article. Clinical Trial.

9

Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.

Zhu W, Mei H, Jia L, Zhao H, Li X, Meng X, Zhao X, Xing L, Yu J. Zhu W, et al. Among authors: zhao h, zhao x. Invest New Drugs. 2020 Aug;38(4):1129-1136. doi: 10.1007/s10637-019-00871-8. Epub 2019 Nov 7. Invest New Drugs. 2020. PMID: 31701429 Clinical Trial.

10

Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer.

Li X, Xing L, Zhang Y, Xie P, Zhu W, Meng X, Wang Y, Kong L, Zhao H, Yu J. Li X, et al. Among authors: zhao h. J Med Food. 2020 Jan;23(1):43-49. doi: 10.1089/jmf.2019.4445. Epub 2019 Nov 20. J Med Food. 2020. PMID: 31747326 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,750 results

Search Page

Filters